| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |